ALMU.NASDAQAeluma, INC

10-Q: Aeluma Boosts Cash, Revenue Amid Operating Loss Increase

Sentiment:

Quarterly Report


Aeluma, Inc. reported increased revenue and a significant cash position following recent public offerings, despite a rise in operating expenses and an ineffective internal control environment.

Capital raiseCompleted an underwritten public offering in March 2025, raising $12.6 million in net proceeds.Completed a second underwritten public offering on September 19, 2025, raising $23.4 million in net proceeds.Management stated no additional equity offerings are planned "at this time" but will monitor capital market conditions and may consider future financing if needed.
Worse than expectedOperating expenses increased by 161%, significantly outpacing revenue growth of 27%.Loss from operations widened substantially from $(0.342) million to $(3.689) million.Disclosure controls and procedures were deemed ineffective, indicating a material weakness in financial reporting oversight.

Summary

  • Revenue for the six months ended December 31, 2025, increased by 27% to $2.7 million, primarily from government contracts.
  • Net loss for the six months ended December 31, 2025, decreased by 8% to $3.3 million compared to $3.6 million in the prior year.
  • Cash and cash equivalents surged to $38.6 million as of December 31, 2025, up from $3.6 million on June 30, 2025, largely due to $36 million in net proceeds from public offerings.
  • Operating expenses increased by 161% to $6.3 million, driven by higher material purchases and increased compensation costs for new employees.
  • The company alleviated substantial doubt about its ability to continue as a going concern for at least the next twelve months.
  • Disclosure controls and procedures were deemed ineffective as of December 31, 2025, with remediation efforts underway including the hiring of a new CFO and additional accounting personnel.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a mixed report. While significant capital raises have alleviated immediate going concern risks and revenue is growing, the substantial increase in operating expenses and the ineffective internal controls present notable challenges that temper overall positive sentiment.

Positives

  • Revenue increased by 27% to $2.7 million for the six months ended December 31, 2025.
  • Net loss decreased by 8% to $3.3 million for the six months ended December 31, 2025.
  • Cash and cash equivalents significantly increased to $38.6 million as of December 31, 2025, from $3.6 million on June 30, 2025.
  • Successfully raised $36 million in net proceeds from two public offerings in March and September 2025.
  • Substantial doubt about the company's ability to continue as a going concern has been alleviated for at least the next twelve months.
  • Appointment of Christopher Stewart as Chief Financial Officer.
  • Increased headcount by eight qualified personnel to support operational and strategic objectives.
  • Expanded facilities with a new 2,400 sq. ft. office space in Goleta, California.

Negatives

  • Operating expenses increased significantly by 161% to $6.3 million for the six months ended December 31, 2025.
  • Loss from operations widened to $3.7 million for the six months ended December 31, 2025, from $0.3 million in the prior year.
  • Disclosure controls and procedures were deemed ineffective as of December 31, 2025, due to insufficient finance staffing and inadequate review controls.
  • Two directors/officers adopted Rule 10b5-1 trading arrangements to sell a combined 250,000 shares.

Risks

  • A prolonged U.S. federal government shutdown could materially and adversely affect business, operations, and legal proceedings.
  • Federal budget and debt-ceiling disputes may adversely affect capital markets and financing activities, potentially impairing the ability to execute at-the-market offerings.
  • The company has a limited operating history and future success is subject to numerous uncertainties and risks inherent in new business development.
  • Despite recent capital raises, there is no assurance that funds will be sufficient to carry out all aspects of the business plan.
  • The company continues to face risks typical of early-stage companies, including limited capital resources, operational and financial challenges, and uncertainty in product development and product-market fit.

Future Outlook

The company expects to continue developing its technology, including novel materials and devices, with a primary focus on manufacturing high-performance semiconductor technologies that scale for mass markets. It plans to mature manufacturing processes, expand business development and marketing, engage with manufacturing partners, and pursue volume production and commercialization. Management believes existing cash, combined with projected revenues and cost management, will be sufficient for working capital and capital expenditures for at least the next twelve months, alleviating prior going concern doubts.

Management Comments

  • Aeluma has pioneered a technique to produce semiconductor materials and chips using high-performance compound semiconductors on large-diameter substrates commonly used to manufacture mass-market microelectronics.
  • Aeluma aims to break out of traditional manufacturing to expand the reach of its technology into mass markets.
  • The demand for higher-performance semiconductors in consumer markets is increasing (Aeluma's disruptive technology is scalable, cost-effective, while not sacrificing performance).
  • No additional equity offerings are planned at this time, but management continues to monitor capital market conditions and may consider future financing if needed.
  • Management has assessed our financial position and operating plan and determined that the previously reported substantial doubt about our ability to continue as a going concern has been alleviated.
  • We believe that our existing cash, cash equivalents, and certificate of deposit, combined with projected revenues and cost management strategies, will be sufficient to meet our working capital and capital expenditure requirements for at least the next twelve months.

Industry Context

StockSavvy.ai notes that Aeluma's focus on heterogeneous integration of compound semiconductors on large-diameter substrates positions it to address the growing demand for high-performance, cost-effective solutions across diverse sectors like AI, automotive, and AR/VR. This approach aims to overcome traditional manufacturing limitations, potentially enabling broader market penetration for advanced semiconductor technologies. The company's continued reliance on government contracts for a significant portion of its revenue, while common for early-stage deep tech firms, highlights the need for successful commercial product diversification to achieve sustained growth in competitive consumer markets.

Comparison to Industry Standards

  • Aeluma's reported 27% revenue growth is positive for an early-stage technology company, though its operating expenses increased by 161%, indicating significant investment in scaling operations and R&D. This level of expense growth is typical for companies in the semiconductor development phase, such as early-stage competitors developing novel chip architectures or advanced materials, which require substantial upfront capital for R&D and infrastructure before achieving economies of scale.
  • The alleviation of going concern doubt is a critical positive, distinguishing Aeluma from many smaller, capital-intensive startups that frequently face liquidity challenges. This improved financial stability, driven by successful public offerings, provides a stronger foundation compared to peers still reliant on venture capital rounds.
  • The disclosure of ineffective internal controls is a notable concern. While remediation efforts are underway, this contrasts with established industry leaders like Intel or TSMC, which maintain robust internal control frameworks due to their scale and regulatory scrutiny. For a smaller, growing company, this issue requires immediate and effective resolution to build investor confidence and ensure financial reporting integrity.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Financial OfficerNAChristopher Stewart2025-08-04Appointment to support operational and strategic objectives and address financial reporting needs.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Disclosure Controls and ProceduresManagement concluded that disclosure controls and procedures were not effective as of December 31, 2025, due to insufficient staffing in the finance department and inadequate precision/timeliness in review controls.2025-12-31Indicates a material weakness in financial reporting oversight, potentially affecting the reliability and timeliness of financial information. Remediation efforts are underway, including hiring a new CFO and additional accounting personnel, which are expected to strengthen the control environment over time.
Insider Trading PolicySteven DenBaars (Board Member) adopted a Rule 10b5-1 trading arrangement to sell up to 100,000 shares. Jonathan Klamkin (President, CEO, Chairman) adopted a Rule 10b5-1 trading arrangement to sell up to 150,000 shares.2025-11-20 (DenBaars), 2025-12-03 (Klamkin)These pre-planned trading arrangements allow insiders to sell shares without being accused of insider trading, but the volume of planned sales by key executives and directors could be perceived negatively by investors, potentially signaling a lack of confidence or a desire to monetize holdings.

Legal Proceedings

  • Not currently involved in any material legal proceedings.
  • Anticipates involvement in legal proceedings, claims, and litigation arising in the ordinary course of business.
  • Potential for material expenses and adverse outcomes that could harm financial position and prospects.

Stakeholder Impact

  • Shareholders: Positive impact from alleviated going concern risk and increased cash reserves, but potential negative sentiment from ineffective internal controls and insider stock sales.
  • Employees: Positive impact from increased headcount and expansion of facilities, indicating growth and job security.
  • Customers (Government Agencies): Continued performance under existing contracts and new awards suggest stable relationships and ongoing service delivery.
  • Creditors: Improved liquidity and financial stability reduce credit risk.

Next Steps

  • Continue to develop technology, including novel materials and devices.
  • Primary focus on manufacturing high-performance semiconductor technologies that scale for mass markets.
  • Mature manufacturing processes to further commercialization traction.
  • Expand business development and marketing efforts.
  • Further engage with manufacturing partners.
  • Continue efforts toward volume production and commercialization, relying on external capabilities for scaling.
  • Implement remediation measures for ineffective disclosure controls and procedures, including recruiting additional accounting personnel.
  • Management will continue to assess capital requirements and may pursue additional financing opportunities.

Key Dates

DateDescription
2023-07-01Company determined one of two lease extension options for Goleta facility was reasonably certain of exercise.
2024-08-00Issued convertible promissory notes in the aggregate principal amount of $3.1 million to 10 accredited investors.
2025-03-00Sold 2,285,571 shares of common stock in an underwritten public offering for gross proceeds of $13.8 million.
2025-03-25A Conversion Event occurred for convertible notes, leading to the issuance of 898,573 shares of Common Stock.
2025-03-26Registration statement on Form S-1 with the SEC was declared effective.
2025-08-04Christopher Stewart appointed as Chief Financial Officer.
2025-09-05Commenced a new five-year operating lease for a second office facility in Goleta, California.
2025-09-19Sold 1,700,000 shares of common stock in an underwritten public offering for gross proceeds of $25.4 million.
2025-11-20Steven DenBaars adopted a Rule 10b5-1 trading arrangement to sell up to 100,000 shares.
2025-12-03Jonathan Klamkin adopted a Rule 10b5-1 trading arrangement to sell up to 150,000 shares.
2025-12-31End of the quarterly reporting period.
2026-02-08Number of common stock shares outstanding was 18,049,306.
2026-02-11Date of filing of the Quarterly Report on Form 10-Q.
2026-06-22Expiration date for 274,255 warrants with an exercise price of $2.00.
2026-06-28Expiration date for 37,058 warrants with an exercise price of $2.00.
2026-07-01Expiration date for 11,393 warrants with an exercise price of $2.00.
2026-09-02Expiration of Jonathan Klamkin's Rule 10b5-1 trading arrangement.
2026-11-19Expiration of Steven DenBaars' Rule 10b5-1 trading arrangement.
2027-12-22Expiration date for 26,762 warrants with an exercise price of $3.00.
2028-01-10Expiration date for 4,542 warrants with an exercise price of $3.00.
2028-03-10Expiration date for 41,738 warrants with an exercise price of $3.00.
2028-03-31Expiration date for 6,660 warrants with an exercise price of $3.00.

Recommendation

hold

The company has significantly improved its liquidity and alleviated immediate going concern risks through successful capital raises, which is a strong positive. Revenue growth is also encouraging. However, the substantial increase in operating expenses leading to a wider operating loss, coupled with the disclosed ineffectiveness of internal controls, introduces significant uncertainty and risk. While the long-term potential of its technology is noted, these operational and governance challenges warrant a cautious 'hold' stance until there is clear evidence of improved cost management and effective internal controls.

Keywords

Aeluma, ALMU, semiconductor, optoelectronic devices, electronic devices, sensing, communication, computing, photodetectors, AI, AR/VR, defense & aerospace, quantum computing, SEC filing, 10-Q, financial results, public offering, cash flow, internal controls, corporate governance, risk factors

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.